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To the Editor:  29 
 30 
Mutations disrupting the Toll-like receptor 3 (TLR3)-dependent-interferon (IFN) pathway can underlie 31 
herpes simplex encephalitis (HSE) of childhood caused by herpes simplex virus-1 (HSV1) infection. These 32 
otherwise healthy HSE patients carry germline mutations in the TLR3-IFN circuit including TRIF and TBK11, 2. 33 
Their dermal fibroblasts show impaired IFN production following HSV1 infection and poly(I:C) stimulation. A 34 
number of these genes (TLR3, TRIF, TBK1) have also been implicated in the process of autophagy. On the other 35 
hand, HSV1 is known to antagonize the antiviral IFN pathway and the autophagy machinery in part via TBK1. 36 
Specifically, TBK1 is targeted by the viral encoded proteins ICP34.5, ICP27, VP24 and UL46, compromising 37 
anti-viral IFN signalling3, 4. In the context of autophagy, TBK1 has been reported to phosphorylate autophagy 38 
receptors such as p62 to promote clearance of intracellular pathogens including HSV1 in vitro5. Herein, we 39 
study the role of autophagy in HSV1 infection using dermal fibroblasts from control and HSE patients with 40 
autosomal dominant (AD) TBK1 (p.G159A/WT) and autosomal recessive TRIF (p.R141X/R141X) deficiencies.  41 
 42 
Despite showing normal autophagy activation after rapamycin and poly(I:C) stimulation, TBK1+/- 43 
fibroblasts showed no induction of autophagy following multiple stimuli: cyclic di-guanylate monophosphate 44 
(c-di-GMP), HSV1 60mer-dsDNA (60mer-dsDNA), and HSV1 infection. Following rapamycin, LC3B punctate 45 
signal increased by 3-fold in both control (media: 20.0%, rapamycin: 72.3%) and TRIF-/-  (media: 21.8%, 46 
rapamycin: 70.0%) fibroblasts, and by 6-fold (media: 11.0%, rapamycin: 61.1%) in TBK1+/- fibroblasts, 47 
suggesting that TRIF and TBK1 were not required for rapamycin-induced autophagy (Fig 1, A and B). To assess 48 
autophagy induced via TLR3, poly(I:C) was used to stimulate fibroblasts leading to a 12-fold (media: 7.1%, 49 
poly(I:C): 86.5%) increase of LC3B puncta in control fibroblasts.  TRIF-/- fibroblasts were unable to induce 50 
LC3B puncta, implicating TRIF in poly(I:C)-induced autophagy. TBK1+/- fibroblasts however showed a 51 
moderate 8-fold (media: 4.0%, poly(I:C): 31.3%) induction of autophagy suggesting its partial role in poly(I:C)-52 
induced autophagy consistent with its partial impairment of poly(I:C)-induced IFN production (Fig 1, A and C)2. 53 
Although the role of dsRNA-TLR3 pathway in regulating autophagy has been documented in other cell lines, its 54 
involvement in infection remains elusive. In addition to TLR3-IFN signaling, TBK1 is also involved in the 55 
HSV1 DNA recognition pathway via STING-TBK1-IRF3 which serves to activate type I IFNs, and STING-56 
dependent autophagy6, 7. To evaluate induction of autophagy via this pathway, fibroblasts were transfected with 57 
c-di-GMP and 60mer-dsDNA, known to stimulate STING-induced autophagy and IFN production6, 7. Whilst 58 
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mock treated fibroblasts did not show significant LC3B induction, we observed a 2-fold (c-di-GMP control: 59 
20.7%, c-di-GMP: 45.2%) and 1.8-fold  (c-di-GMP control: 18.5%, c-di-GMP:  33.6%) increase in punctate 60 
LC3B in control and TRIF-/- fibroblasts respectively when transfected with c-di-GMP, compared to the c-di-61 
GMP control. Significant induction of LC3B puncta following 60mer-dsDNA transfection was also observed in 62 
control and TRIF-/- fibroblasts by 4-fold (media: 19.6%, 60mer-dsDNA: 84.8%) and 2-fold (media: 28.0%, 63 
60mer-dsDNA: 67.6%) respectively. However, c-di-GMP and 60mer-dsDNA stimulation failed to induce LC3B 64 
puncta in TBK1+/- fibroblasts (Fig 1, A, D and E) suggesting TBK1 is essential for dsDNA-induced autophagy. 65 
 66 
In control fibroblasts, HSV1 infection triggered a 10-fold (non-infected: 0.2 a.u., infected MOI 5: 1.8 67 
a.u.) increase in LC3BII:I and a 2-fold (non-infected: 1.0 a.u., infected MOI 5: 0.5 a.u.) reduction in p62 protein 68 
indicating activation of autophagy, as assessed by western blot (Fig 1, F). TRIF-/- fibroblasts also showed a 6-69 
fold (non-infected: 0.2 a.u., infected MOI 5: 1.2 a.u.) LC3BII:I increase following infection at MOI 5. TBK1+/- 70 
fibroblasts however showed no change in LC3BII:I or p62 following HSV1 infection suggesting impaired 71 
HSV1-induced autophagy. Depletion of endogenous TBK1 using siRNA in control fibroblasts recapitulated this 72 
impairment (Fig 1, G). Using immunofluorescence imaging, we found that HSV1 infection triggers two LC3B 73 
phenotypes in control fibroblasts: perinuclear LC3B puncta in infected cells and cytoplasmic LC3B puncta in 74 
antigen-negative-plaque-neighbouring (‘antigen-negative’) cells (Fig 2, A). Whilst the former occurs later in 75 
infection and is likely the phenomenon termed nuclear develop-derived autophagy (NEDA) as it also stained 76 
with LC3A8 (Fig 2, A), cytoplasmic LC3B formed early in infection (up to 3 hours post-infection) (Fig 2, B). 77 
Strikingly, TBK1+/- fibroblasts failed to form cytoplasmic LC3B puncta in antigen-negative cells, despite being 78 
able to form perinuclear LC3B later in infection (Fig 2, A and B). Furthermore, inhibiting TBK1 in control 79 
fibroblasts using BX795 resulted in significant reduction in cytoplasmic LC3B formation (see Fig E1 in this 80 
article’s Online Repository at www.jacionline.org). Whilst the lack of early autophagic induction was specific to 81 
TBK1+/- fibroblasts, TRIF-/- fibroblasts only showed delayed induction of autophagy (see Fig E2 in this article’s 82 
Online Repository at www.jacionline.org), suggesting its partial involvement in HSV1-induced autophagy. The 83 
antigen-negative LC3B puncta has been previously reported in HSV1-infected mice trigeminal neurons but was 84 
shown to be cGAMP-independent and IFN-dependent9. In contrast to this, we find this phenomenon to be 85 
TBK1-dependent and IFNβ-independent since TRIF-/- fibroblasts, shown to have undetectable IRF3 86 
phosphorylation and IFNs after HSV1 infection1 (see Fig E3, A and E4 in this article’s Online Repository at 87 
www.jacionline.org), were able to induce this phenotype. Furthermore, IFN treatment was able to induce 88 
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autophagy in TBK1+/- fibroblasts, ruling out the role of IFN in inducing cytoplasmic LC3B puncta in HSV1 89 
infection (see Fig E5 in this article’s Online Repository at www.jacionline.org). TBK1+/- fibroblasts also failed 90 
to reduce STING following HSV1 infection in contrast to control and TRIF-/- fibroblasts suggesting HSV1 91 
induction is STING dependent (see Fig E3, B). We confirmed similar HSV1-induced autophagy phenotypes in 92 
primary fibroblasts from which these SV40-immortalized cell lines were derived from (see Fig E6 in this 93 
article’s Online Repository at www.jacionline.org). These results show that the two types of autophagy differ in 94 
localization (cytoplasmic vs perinuclear) and temporal response to HSV1 infection, implying that they have 95 
different functions. We decided to focus on the TBK1-dependent early cytoplasmic phenotype as the later 96 
perinuclear LC3B, likely NEDA, was induced in all cells and has been reported to be a generalized stress 97 
response to viral late protein production8. 98 
 99 
 We next sought to understand how the different triggers of autophagy affect HSV1 infection. 100 
Following pre-treatment with poly(I:C), HSV1 replication was significantly reduced in control fibroblasts which 101 
can be attributed to the production of IFNβ (Fig 2, C and D). Consistently, with a low dose of HSV1, no viral 102 
plaque was observed in control fibroblasts which exhibited cytoplasmic puncta in response to the poly(I:C) 103 
treatment (Fig 2, C, D, E and G). Interestingly, poly(I:C)-induced LC3B puncta in TBK1+/- fibroblasts was 104 
detectable following HSV1 infection. This pre-enhanced autophagy and IFNβ production in TBK1+/- fibroblasts 105 
however did not improve cell viability or viral replication in contrast to control fibroblasts (Fig 2, C-G). TRIF-/- 106 
fibroblasts failed to induce autophagy or IFNs following poly(I:C) treatment1 and hence were not protected 107 
against HSV1 infection (Fig 2, D). Notably however, cytoplasmic LC3B puncta was present upon HSV1 108 
infection of TRIF-/- fibroblasts, confirming that the formation of cytoplasmic LC3B puncta is IFN-independent 109 
(Fig 2, C, D and G, Fig E3, A and E4). Rapamycin pre-treatment led to the induction of autophagy in control, 110 
TRIF-/- and TBK1+/- fibroblasts as expected (Fig 2, C and G). In control and TRIF-/- fibroblasts, upregulating 111 
autophagy using rapamycin prior to HSV1 infection resulted in the same proportion of cytoplasmic LC3B 112 
puncta post-infection (non-treated infected vs rapamycin infected) (Fig 2, C and G). In contrast, rapamycin pre-113 
treated TBK1+/- fibroblasts showed a 4-fold (non-treated infected: 8.7% vs rapamycin-infected: 35.5%) increase 114 
of cytoplasmic LC3B puncta in antigen-negative fibroblasts following HSV1 infection (Fig 2, C and G). 115 
Rapamycin pretreatment did not affect viral replication in all cells however it significantly improved cell 116 
viability of TBK1+/- cells (non-treated: 55.0% vs rapamycin treated: 76.7%) (Fig 2, E, F and G). Taken together, 117 
this shows that rapamycin-induced autophagy selectively increased the number of cytoplasmic LC3B, which 118 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
confers a cytoprotective effect by increasing cell viability in TBK1+/- fibroblasts. This protective effect of 119 
rapamycin could not be attributed to IFNβ as rapamycin did not induce IFNβ (Fig 2, D).  120 
 121 
 In conclusion, we show that in addition to its antiviral role in IFN production via TLR3 and STING1, 2, 122 
6
, TBK1 induces autophagy upon HSV1 infection. We demonstrate that TBK1-induced autophagy occurs early 123 
during HSV1 infection in antigen-negative fibroblasts, can be mediated by c-di-GMP or HSV1 dsDNA and is 124 
TLR3- and IFN-independent. TBK1+/- fibroblasts derived from a HSE patient harboring a dominant negative 125 
mutation had a selective impairment of autophagy induction early in infection represented by the lack of 126 
cytoplasmic LC3B puncta formation. We believe that host or viral induced factors, possibly acting as danger 127 
signals, can trigger autophagy in antigen-negative fibroblasts promoting cell survival without influencing viral 128 
replication. This study highlights a possibly cytoprotective role for TBK1 in HSV1-induced autophagy which 129 
may serve to control inflammation and has potential implications for patients with HSE. 130 
 131 
Liyana Ahmad, PhDa 132 
Bayarchimeg Mashbat, PhDb 133 
Corwin Leung, MSca  134 
Charlotte Brookes, MSca  135 
Samar Hamad, MSca  136 
Sina Krokowski, MScc,d   137 
Avinash R. Shenoy, PhDe 138 
Lazaro Lorenzo, MScf,g,  139 
Michael Levin, MD PhDb 140 
Peter O’Hare, PhDa 141 
Shen-Ying Zhang, MD, PhDf,g,h  142 
Jean-Laurent Casanova, MD, PhDf,g,h,i,j  143 
Serge Mostowy,PhDc,d  144 
Vanessa Sancho-Shimizu, PhDa,b* 145 
 146 
From aDepartment of Virology, Division of Medicine, Imperial College London, Norfolk Place, London W2 147 
1PG, UK; bDepartment of Paediatrics, Division of Medicine, Imperial College London, Norfolk Place, London 148 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
W2 1PG, UK; cMRC Centre of Molecular Bacteriology and Infection (CMBI), Imperial College London, 149 
London, SW7 2AZ, UK; dDepartment of Immunology and Infection, London School of Hygiene and Tropical 150 
Medicine, London, WC1E 7HT, UK; eSection of Microbiology, Medical Research Council Centre for Molecular 151 
Bacteriology and Infection, Imperial College London, London, SW7 2AZ, UK; fLaboratory of Human Genetics 152 
of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France; gUniversity Paris Descartes, Imagine 153 
Institute, Paris, France; hSt. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, 154 
The Rockefeller University, New York, NY, USA; iHoward Hughes Medical Institute, New York, NY, USA; 155 
jPediatric Hematology and Immunology Unit, Necker Hospital for Sick Children, Paris, France. 156 
 157 
*Correspondence: v.sancho-shimizu@imperial.ac.uk 158 
LA was supported by the Chancellor’s scholarship of Universiti Brunei Darussalam, VSS is a Medical Research 159 
Foundation fellow and the work described has been supported by this grant. 160 
 161 
REFERENCES 162 
1. Sancho-Shimizu V, Pérez de Diego R, Lorenzo L, Halwani R, Alangari A, Israelsson E, et al. Herpes 163 
simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency. J Clin Invest 164 
2011; 121:4889–902.  165 
2. Herman M, Ciancanelli M, Ou Y-H, Lorenzo L, Klaudel-Dreszler M, Pauwels E, et al. Heterozygous 166 
TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood. J Exp 167 
Med 2012; 209:1567–82.  168 
3. Verpooten D, Yijie M, Hou S, Yan Z, He B. Control of TANK-binding kinase 1-mediated signaling by 169 
the gamma(1)34.5 protein of herpes simplex virus 1. J Biol Chem 2009; 284:1097–105.   170 
4. Zheng C. Evasion of Cytosolic DNA-Stimulated Innate Immune Responses by HSV-1. J Virol 2018. 171 
5. Sparrer KMJ, Gableske S, Zurenski MA, Parker ZM, Full F, Baumgart GJ, et al. TRIM23 mediates 172 
virus-induced autophagy via activation of TBK1. Nat Microbiol 2017; 2:1543–57.   173 
6. Burdette DL, Monroe KM, Sotelo-Troha K, Iwig JS, Eckert B, Hyodo M, et al. STING is a direct 174 
innate immune sensor of cyclic di-GMP. Nature 2011; 478:515–8.   175 
7. Rasmussen SB, Horan KA, Holm CK, Stranks AJ, Mettenleiter TC, Simon AK, et al. Activation of 176 
autophagy by alpha-herpesviruses in myeloid cells is mediated by cytoplasmic viral DNA through a 177 
mechanism dependent on stimulator of IFN genes. J Immunol 2011; 187:5268–76.  178 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
8. Radtke K, English L, Rondeau C, Leib D, Lippe R, Desjardins M. Inhibition of the host translation 179 
shutoff response by herpes simplex virus 1 triggers nuclear envelope-derived autophagy. J Virol 2013; 180 
87:3990–7.   181 
9. Katzenell S, Leib DA. Herpes Simplex Virus and Interferon Signaling Induce Novel Autophagic 182 
Clusters in Sensory Neurons. J Virol. 2016; 90:4706–19. 183 
 184 
FIGURE LEGENDS 185 
FIG 1. TBK1+/- fibroblasts show impaired cytosolic-dsDNA- and HSV1-induced autophagy. (A) 186 
Immunofluorescence images of LC3B puncta (green) and DAPI (blue) in fibroblasts. Quantification of LC3B 187 
puncta positive fibroblasts stimulated with (B) rapamycin, (C) poly(I:C), (D) cdi-GMP or cdi-GMP control, and 188 
(E) 60mer-dsDNA. (F) Immunoblots and densitometric graphs of HSV1-infected fibroblasts. (G) Immunoblot 189 
confirming TBK1 siRNA knockdown in control fibroblasts; immunoblots for LC3B, p62, GAPDH in HSV1-190 
infected TBK1 knockdown fibroblasts. Viral titre and immunofluorescence images of infected TBK1 191 
knockdown fibroblasts. L; Lipofectamine, (all experiments were performed at least three times; means ± SEM; 192 
****P <0.0001, ***P <0.001 and *P <0.05). 193 
 194 
FIG 2. TBK1+/- fibroblasts lack cytoplasmic LC3B puncta induced early in HSV1 infection. (A, B, C) 195 
Immunofluorescence images of fibroblasts stained for HSV1 ICP4 (red), LC3B or LC3A (green), and DAPI 196 
(blue). White arrows indicate cytoplasmic LC3B, yellow arrows indicate perinuclear LC3A/B. Dashed lines 197 
mark the plaque boundary. (D) IFNβ production, (E) viral titre, (F) cell viability and (G) cytoplasmic LC3B 198 
puncta positive fibroblasts were quantified. n.d., not-detectable, (n=3; means ± SEM; ****P <0.0001, ***P 199 
<0.001, **P <0.01 and *P <0.05). 200 
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Legends for Online Repository Figures  1 
 2 
Fig E1 - TBK1 inhibition reduced cytoplasmic LC3B puncta formation but did not 3 
affect perinuclear LC3B formation following HSV1 infection (A) Control and TBK1+/- 4 
fibroblasts were pre-treated with 1 µM of BX795 for 16 hours before infecting with HSV1 5 
(MOI 10) for indicated length of time, and being fixed and stained for LC3B (green) and/or 6 
ICP4 (red). DAPI (blue) was used the nuclear stain. The scale bar of each representative 7 
image is 20 µm. Inset represents the magnified view of the indicated area and has a scale bar 8 
of 10 µm. White arrows indicate cytoplasmic LC3B, while yellow arrows indicate perinuclear 9 
LC3B. (B) The percentage of cells positive for cytoplasmic LC3B puncta in (A) was counted 10 
on a minimum number of >100 cells. Images are representative of three independent 11 
experiments (n=3). Data are represented as mean ± SEM and were analysed by two-way 12 
ANOVA; **P<0.01. 13 
 14 
Fig E2 - TRIF-/- fibroblasts showed delayed cytoplasmic LC3B puncta formation – (A) 15 
Fibroblasts grown on coverslips were infected with HSV1 (MOI 10) for indicated lengths of 16 
time before being fixed and stained for endogenous LC3B (green) and/or HSV1 ICP4 (red) 17 
proteins. DAPI (blue) was used as the nuclear stain. The scale bar of each representative 18 
image is 20 µm. Inset represents the magnified view of the indicated area and has a scale bar 19 
of 10 µm. White arrows indicate cytoplasmic LC3B, while yellow arrows indicate perinuclear 20 
LC3B. (B) The percentage of cells positive for cytoplasmic LC3B puncta in (A) was counted 21 
on a minimum number of >100 cells. Images are representative of three independent 22 
experiments (n=3). Data are represented as mean ± SEM and were analysed by two-way 23 
ANOVA;  ***P<0.001 and ****P<0.0001. 24 
 25 
Fig E3 – Endogenous protein levels of TBK1, IRF3, phosphorylated IRF3 and STING 26 
during HSV1 infection. Control, TRIF-/- and TBK1+/- fibroblasts were infected with HSV1 27 
(MOI 1) for indicated lengths of time. Whole-cell lysates were electrophoresed and probed 28 
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for endogenous (A) TBK1, IRF3 phosphorylated IRF3 and (B) STING proteins. GAPDH was 29 
used a loading control. Relative level of STING to GAPDH was measured by densitometry. 30 
 31 
Fig E4 – TRIF-/- and TBK1+/- fibroblasts showed impaired IFNβ production following 32 
HSV1 infection. Control, TRIF-/- and TBK1+/- fibroblasts were infected with HSV1 at 33 
indicated MOIs for 24 hours before collecting supernatants and measuring IFNβ by ELISA. 34 
Data are represented as mean ± SEM and were analysed by two-way ANOVA; n=3;  *P<0.05 35 
and ****P<0.0001. 36 
 37 
Fig E5 - IFN-induced autophagy in fibroblasts (A) Control, TRIF-/- and TBK1+/- fibroblasts 38 
were stimulated with 1X105 IU/mL of IFNα-2A for 24 hours before being fixed and stained 39 
for endogenous LC3B (green). DAPI (blue) was used as the nuclear stain. The scale bar of 40 
each representative image is 20 µm. Inset represents the magnified view of the indicated area 41 
and has a scale bar of 10 µm. White arrows indicate LC3B puncta. Images are representative 42 
of three independent experiments (n=3) 43 
 44 
Figure E6 - Primary fibroblasts showed similar HSV1-induced autophagy phenotypes to 45 
SV40-transformed fibroblasts. Primary fibroblasts grown on coverslips were infected with 46 
HSV1 (MOI 10) for 3 or 8 hours before being fixed and stained for endogenous LC3B (green) 47 
and/or HSV1 ICP4 (red) proteins. DAPI (blue) was used as the nuclear stain. The scale bar of 48 
each representative image is 20 µm. Inset represents the magnified view of the indicated area 49 
and has a scale bar of 10 µm. White arrows indicate cytoplasmic LC3B, while yellow arrows 50 
indicate perinuclear LC3B. Images are representative of three independent experiments  51 
(n=3).  52 
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METHODS 1 
 2 
Cell lines  3 
Human SV40-immortalized dermal fibroblasts from healthy control, TBK1+/- (p.G159A), TRIF-/- 4 
patientsE1, E2, and Vero (African green monkey kidney) cells were maintained in 5% CO2 incubator at 5 
37oC in DMEM supplemented with 10% fetal bovine serum (FBS).  6 
 7 
Viral infection and quantification  8 
Human fibroblasts were infected with HSV1-GFP (KOS strain with GFP-tagged capsid protein VP26) 9 
or HSV1 (strain 17AR+) at various MOIs and timepoints for immunoblot and immunofluorescence 10 
experiments. After 1 hour infection in DMEM supplemented with 2% FBS, the virus was removed and 11 
new media added with 1% HSV1 human neutralizing antibody. Viral titres were determined by 12 
infecting a confluent monolayer of Vero cells in a 12-well or 96-well plate, and performing plaque 13 
assay on them or calculating the 50% end point (TCID50/mL)E3.  14 
 15 
Stimulation and treatments 16 
Fibroblasts cells were stimulated with 25 µg/mL of poly(I:C) (GE Healthcare), 10 nM of rapamycin 17 
(Calbiochem) or 1X105 IU/mL of IFNα-2A (PBL Assay Science) for 24 hours, or treated with 1µM of 18 
TBK1 inhibitor BX795E4 (Sigma) for 16 hours, or transfected with 8 µg/mL of c-di-GMP (Invivogen) 19 
or c-di-GMP control (Invivogen) for 2 hours, or 2 µg/mL of HSV1 dsDNA (60mer sequence: 5′-20 
TAAGACACGATGCGATAAAATCTGTTTGTAAAATTTATTAAGGGTACAAATTGCCCTAGC-21 
3′; Integrated DNA Technology) for 3 hours. C-di-GMP, c-di-GMP control and HSV1 dsDNA were 22 
delivered by Lipofectamine® 2000 (L) transfection. For pre-treatment experiments, fibroblast were 23 
incubated with either rapamycin or poly(I:C) for 16 hours before infecting with HSV1.  24 
 25 
Cell viability assay 26 
Cells were plated in a flat-bottomed 96-well plate in triplicates at a density of 0.18X106 cells/mL in 27 
10% FBS-supplemented DMEM. Fibroblasts were pre-treated for 16 hours before being infected with 28 
HSV1 MOI of 1 for 24 hours. The viability of fibroblasts was measured using CellTiter 96® AQueous 29 
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Non-Radioactive Cell Proliferation Assay (MTS) kit (Promega) and performed as per manufacturer’s 30 
instructions. Cell viability was determined by normalizing to non-infected cells of each cell line. 31 
 32 
RNA interference 33 
Cells were seeded in 10% FBS-supplemeted DMEM at 0.05X106 cells/well in a flat-bottomed 24-well 34 
plate and incubated for 18 hours in 37oC humidified incubator. Medium was then replaced with fresh 35 
2% FBS-supplemented DMEM and cells were transfected with 15 nM of scramble (siNegative) 36 
(Ambion) or pooled three TBK1-specific (siTBK1) small interfering RNAs (siRNAs) (siRNA ID no. 37 
134003, 134002 & 899, Ambion) at 80% confluency using Lipofectamine® RNAiMAX vector (Life 38 
Technologies) and incubated for further 48 hours in 37 oC incubator.  39 
 40 
Immunofluorescence and quantification of puncta-positive cells 41 
Cells were grown at 50% confluency on 13 mm diameter coverslips and fixed with 100% methanol on 42 
ice, before washing them with 1X phosphate buffered saline (PBS). Blocking was done in 10%-FBS 43 
PBS and cells were permeabilized with 0.1% TritonX-100 in PBS. Staining was done in a moist 44 
chamber using the following antibodies:  LC3B (1:500 dilution, Abcam), cleaved LC3A (1:100 45 
dilution, Stratech), HSV1 immediate early protein ICP4 (clone 10F1) (1:500 dilution, Virusys), Alexa 46 
Fluor-488 and -594 conjugated secondary antibodies (1:750 and 1:1000 dilutions respectively, Life 47 
Technologies). Images were taken with 63X oil-immersion lens on a widefield fluorescence 48 
microscope (Zeiss Axio Observer). The number of LC3B puncta-positive cells was quantified on a 49 
minimum number of 100 cells per experiment.  50 
 51 
Immunoblotting  52 
Whole-cell lysates of fibroblasts infected with HSV1 for 48 hours were harvested in 1X Laemmli 53 
buffer supplemented with protease inhibitor cocktail (Roche), 10% β-mercaptoethanol and 1:1000 of 54 
benzonase nuclease (Sigma). Lysates were denatured and electrophoresed on 12% tris-glycine or 10% 55 
bis-tris gels (Biorad). Proteins were transferred onto PVDF membrane (Invitrogen), probed with 56 
primary and secondary horse-radish peroxidase (HRP)-conjugated antibodies (1:1000 and 1:10, 000 57 
dilution respectively) and subsequently detected using enzyme-chemiluminescent reagents (GE 58 
Healthcare). For LC3B immunoblots, bafilomycin A1 (Sigma) was added to culture medium for 6 59 
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hours prior to lysis for immunoblotting to block LC3BII recycling to LC3BI. The following antibodies 60 
were used for immunoblotting: LC3B (Cell Signaling Technology), p62 (MBL International), TBK1 61 
(Cell Signaling Technology), IRF3 (D83B9) (Cell Signaling Technology), IRF3-phospho (S396) (Cell 62 
Signaling Technology), STING (D2P2F) (Cell Signaling Technology), and GAPDH-HRP (Santa Cruz 63 
Biotech). GAPDH was used as a loading control.  64 
 65 
ELISA 66 
IFNβ secretion in recovered supernatants of cells pre-treated with rapamycin or poly(I:C) for 24 hours 67 
was measured using the VeriKine-HSTM human IFNβ serum ELISA kit (assay range: 1.2 – 150 pg/mL) 68 
(PBL Assay Science) following the manufacturer’s instructions.  69 
 70 
Statistical analysis and software 71 
Immunofluorescence images were analysed by Icy software. Densitometric analyses of immunoblots 72 
were carried out using ImageJ. Statistical significance was assessed by two-way ANOVA using Prism 73 
7 (Graphpad) software. Number of fluorescent cells or LC3B puncta-positive cells was quantified using 74 
ImageJ software. All experiments were performed at least 3 times.  75 
 76 
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